"Current selling is painful but taking a longer term view I still think this could end up being similar to Rand/Tribune" I think Anton Billis agrees with you, he does hold 6.3% of TNR.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025